Juyong Kim, MD
Interventional Cardiology · Stanford, CANPI 1043462146
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,060 of the $1,536 with a category attached, or 69.1%. Janssen Research & Development, LLC accounts for 89.2% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for interventional cardiology clinicians in CA, where the typical reported total is $8,581.
Across 11 payments — averaging $139.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$1K
- Boston Scientific$165
Across 25 payments — averaging $6806.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$170K
What the payments were for
- Travel & lodging$1,06069%
- Food & beverage$47531%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 10 | $1,370 |
| Boston Scientific | 1 | $165 |
How this compares
$1,536 in reported general payments places this provider in the 15th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 23 | $948 |
| Atorvastatin Calcium | 37 | $519 |
| ClopidogrelClopidogrel Bisulfate | 29 | $473 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $292 |
| Carvedilol | 11 | $289 |
| Metoprolol Succinate | 28 | $275 |
| Amlodipine Besylate | 17 | $44 |
| Metoprolol Tartrate | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Stanford
- Rahul SharmaStanford$1M
- Jennifer TremmelStanford$233K
- David LeeStanford$231K
- Todd BrintonStanford$150K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.